Jaclyn Delgreco, DO
Family Medicine · Masontown, PANPI 1669793907
Payments from drug & device makers
Across 131 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$443
- AbbVie$372
- Pfizer$283
- Novo Nordisk$245
- Lilly USA, LLC$180
- Amgen$123
- plus $813 from 17 others
What the payments were for
- Food & beverage$2,459100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 26 | $443 |
| AbbVie | 15 | $372 |
| Pfizer | 18 | $283 |
| Novo Nordisk | 13 | $245 |
| Lilly USA, LLC | 11 | $180 |
| Amgen | 8 | $123 |
| Bayer | 6 | $120 |
| AstraZeneca | 7 | $114 |
| Medtronic | 3 | $74 |
| Astellas Pharma US Inc | 3 | $64 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $62 |
| Abbott | 2 | $48 |
| Merck | 3 | $45 |
| Dynavax Technologies Corporation | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Edwards Lifesciences | 1 | $37 |
| Novartis | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Dexcom, Inc. | 2 | $31 |
| Amarin Pharma, Inc. | 1 | $24 |
| Corium, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
| Pulmonx Corporation | 1 | $13 |
How this compares
$2,459 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $74,093 |
| JardianceEmpagliflozin | 72 | $72,591 |
| OzempicSemaglutide | 52 | $61,814 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $51,242 |
| MounjaroTirzepatide | 36 | $39,538 |
| TrulicityDulaglutide | 36 | $37,996 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $21,224 |
| LinzessLinaclotide | 19 | $14,533 |
| Incruse ElliptaUmeclidinium Bromide | 23 | $14,080 |
| MyrbetriqMirabegron | 17 | $13,291 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $11,269 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $6,223 |
| Atorvastatin Calcium | 553 | $4,606 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $4,097 |
| Pantoprazole Sodium | 172 | $3,968 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta | $443 | $97,815135 claims |
| Lilly USA, LLCMounjaro, Trulicity | $180 | $77,53472 claims |
| PfizerEliquis, Premarin | $283 | $75,39594 claims |
| Novo NordiskOzempic | $245 | $61,81452 claims |
| AbbVieLinzess, Synthroid | $372 | $16,66379 claims |
| Astellas Pharma US IncMyrbetriq | $64 | $13,29117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Masontown
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.